Formerly Office of Director General, World Health Organization, Geneva, Switzerland.
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
J Psychoactive Drugs. 2023 Nov-Dec;55(5):519-522. doi: 10.1080/02791072.2023.2268610. Epub 2023 Oct 24.
The global prevalence of substance abuse and mental disorders continues to challenge healthcare systems, with one in eight individuals affected. The therapeutic potential of psychedelics is recognized not only for treating mental disorders but also for enhancing well-being and promoting pro-social behaviors. Conventional biomedical research models fall short in addressing the broader health needs of populations and poorly suited for overcoming barriers to service delivery. This special issue includes six articles that explore alternative approaches to psychedelic research and practice, emphasizing collaboration with diverse actors, including indigenous communities, and incorporating traditional knowledge systems into contemporary psychedelic research. They underscore the need for innovative research methods that engage multidisciplinary approaches while promoting culturally relevant outcome measures. They emphasize the importance of shifting from punitive drug policies to those grounded in public health and human rights, allowing for multi-country studies and the development of evidence-based care models for community mental health. Incorporating traditional knowledge and community-based methodologies into psychedelic science is vital for its evolution beyond biomedical research for widespread dissemination, offering new avenues for improved health outcomes and promotion of human flourishing.
全球物质滥用和精神障碍的患病率持续挑战着医疗体系,每 8 个人中就有 1 人受到影响。迷幻剂的治疗潜力不仅在于治疗精神障碍,还在于增强幸福感和促进亲社会行为。传统的生物医学研究模式在满足人群更广泛的健康需求方面存在不足,也不适合克服服务提供的障碍。本期特刊包含六篇文章,探讨了迷幻剂研究和实践的替代方法,强调与包括土著社区在内的各种行为者合作,并将传统知识体系纳入当代迷幻剂研究。它们强调需要创新研究方法,采用多学科方法,同时促进具有文化相关性的结果衡量标准。它们强调需要从基于惩罚的毒品政策转向基于公共卫生和人权的政策,允许进行多国研究,并为社区心理健康制定基于证据的护理模式。将传统知识和基于社区的方法纳入迷幻科学对于其超越生物医学研究的广泛传播至关重要,为改善健康结果和促进人类繁荣提供了新途径。